Case Report

A Case of Invasive Adenocarcinoma Arising from Heterotopic Pancreas in the Stomach and Review of the Literature

Roberto Bini1, Franco Coppola2, Antonella La Terra2, Tiziana Viora1, Renzo Leli3* and Alfredo Addeo3*
1Department of General and Emergency Surgery, SG Bosco Hospital, Italy
2Department Oncology, Bristol Cancer Center, UK
3Department of Gastrointestinal Endoscopy, SG Bosco Hospital, UK


*Corresponding author: Renzo Leli and Alfredo Addeo, Department of Gastrointestinal Endoscopy, SG Bosco Hospital, UK

Published: 05 Sep, 2017
Cite this article as: Bini R, Coppola F, La Terra A, Viora T, Leli R, Addeo A. A Case of Invasive Adenocarcinoma Arising from Heterotopic Pancreas in the Stomach and Review of the Literature. Clin Oncol. 2017; 2: 1333.

Abstract

Heterotopic pancreas is a rare condition of tissue found outside the pancreas without anatomic connection with ectopic one. Generally asymptomatic and incidentally findings could be located elsewhere in the gastrointestinal tract. Degeneration into neoplasm is rare. Less than sixteen cases has been describe. Our case is the first well reported an adenocarcinoma arising from a locally advanced stomach’s HP discovered for hematemesis.


Introduction

The Heterotopic Pancreas (HP) is defined as a pancreatic tissue found outside the eutopic pancreas without anatomic or vascular connections between them.
It is not uncommon with an incidence of approximately 0.5% - 13.7% in autopsy studies and 0.5% in upper abdominal laparotomies and It can be found anywhere in the gastrointestinal tract. The most common site is the stomach, mostly in the antrum and prepyloric region on the greater curvature or posterior wall. The heterotopic pancreas is usually an incidental finding, however, mass-like manifestations causing pyloric obstruction, ulcer, and bleeding can be observed in the gastric area [1].
We report a case of a patient with HP of the stomach who developed an invasive adenocarcinoma presenting with hematemesis.


Case Report

A 76 years old woman, with a past medical history of hypertension, under evaluation for anemia, was admitted to the Emergency Department (ED)with melena and hematemesis. Hemoglobin was 6.2 g/dl, red blood cell 2.3 x 106, Hematocrit 22%, elevated lactate and Base Deficit (BD). Her blood pressure was 75 over 55 mmHg and 120 heart pulse rate, euthermic, skin pale and clammy. Coagulation screening was within normal value. She received fluids and blood units. She subsequently underwent Oesophago-Gastro-Duodenoscopy (OGD) that revealed the presence of a blood clot occupying the body of the stomach. During the admission she became unstable so an angio-Computed Tomography (CT) was performed. That showed a neoplastic lesion involving the body of the stomach, transverse colon, distal pancreas and spleen (Figure 1). Due to presence of multiple collateral vessels feeding the lesion with high risk of massive necrosis embolization was not performed.
A gastrectomy, spleno-pancreasectomy and resection of the transverse colon with Roux and Y esophagojejunostomy and end to end colo-colic anastomosis was perfomed.
In the first post-operative period the patient developed Acute Respiratory Distress Syndrome (ARDS) and required external ventilation and hemodynamic support in intensive care unit. The histology revealed/showed adenocarcinoma (pTN4N2M0) (Figure 2 and 3). After 24 days the patient was discharged and referred to the oncological department.
Due to comorbidity she wasn’t deemed fit for any oncological therapy and, after one year, she died for the progression of her disease.


Figure 1

Another alt text

Figure 1
CT scan of the neoplasm arising from EP in stomach (white arrow).

Figure 2

Another alt text

Figure 2
Haematoxylin and Eosin 100X. Ectopic pancreas.

Figure 3

Another alt text

Figure 3
Haematoxylin and Eosin 50X. Passage from HP (in the lower portion of the image) and neoplasm (in the upper part of the image).

Discussion

HP is often and incidental finding and many patients with HP are asymptomatic and require no treatment [2]. The rate of HP during autopsy varies from 0.6% to 15% and about 75% of ectopic pancreases are found in the stomach, duodenum, or ileum [3]. In the stomach, HP is most often located along the greater curve of the prepyloric antrum and especially within 6 cm of the pyloric ring. HP are usually less than 4 cm in size, and a central mucosal depression is often recognized at endoscopy. An ectopic pancreas usually invades the submucosa or muscle layer, and has histologically normal pancreatic tissue [4].
Histology confirmation and diagnosis that a malignant tumor has raised from pre-existing ectopic pancreatic tissue may be rather difficult [5]. Described three criteria to prove that a malignancy arose from an ectopic pancreas: 1) the tumor must be within or near the ectopic pancreatic tissue; 2) a direct transition between pancreatic structures and carcinoma must be observed; 3) the non-neoplastic pancreatic tissue must, at a minimum, be fully developed.
Heinrich classified the heterotopic pancreas into 3 types [6]: type I, all the components of the pancreas including ducts, acini, and endocrine islets; type II, ducts with acini; and type III, ducts with a few acini or dilated ducts only, so called adenomyoma. When the pancreaticobiliary-type ducts predominate, they are often surrounded by hypertrophic smooth muscle bundles.
In a series of 32 cases ofsymptomatic HP none of the patients was diagnosed preoperatively [7]. Barium swallow studies may show arounded filling defect, sometimes with central indentation. Imaging studies with endoscopic ultrasound (EUS) and (CT) are frequently used for thediagnosis of gastrointestinal submucosal tumor and can behelpful in the diagnosis of gastric HP, but are not specific [8]. However, studies have suggested that both EUS and CT help to distinguish HP from other submucosal tumors. Endoscopic appearance of HP is thatof a well circumscribed submucosal mass with a normal overlying mucosa and a central dimpling which corresponds with the opening of a duct. The characteristic dimplingor umbilication is observed in less than half of the cases, and therefore, HP may easily be misinterpreted as another submucosal tumor such as stromal tumor, or leiomyoma atendoscopic examination. Because GISTs are by far the most common gastric submucosal tumors, HP can frequently be mistaken for GIST at endoscopy as happened in our case [9]. Endoscopic biopsy performed by using standard biopsy forceps is most often unremarkable. However, a few reported cases of HP were diagnosed with biopsies obtained with the jumbo forceps [10]. Diagnosis can occasionally be made through endoscopical biopsies but those are inconclusive in about 50% of the cases as normal gastric mucosa could cover the HP [11].
EUS-guided aspiration has been reported to be helpful to diagnose HP [12]. If an endoscopic resection is considered, EUS is also extremely useful for pre-excision assessment. There was no correlation between the histological type of HP and the presence of symptoms. Surgery is frequently needed to make a definitive diagnosis and to plan further treatment because the differential diagnosis includes leiomyoma, lymphoma, carcinoid tumors, and other malignancies [11].
If HP is diagnosed as an incidental finding, local excision is recommended. Symptomatic HP should be resected. Endoscopic excision can be considered in select cases depending on the size and location of the mass, especially for treating the benign lesions of HP.
Because the preoperative imaging studies (ultrasonography, endoscopic ultrasonography and computerized tomography) are not very specific [13], intraoperative frozen section studies are useful to confirm the diagnosis and exclude the most common differential diagnosis of HP such as gastrointestinal stromal tumor, gastrointestinal autonomic nerve tumor, lymphoma, carcinoid tumor and other malignancies. Recently, the combination of endoscopic ultrasonography with fine needle aspiration cytology from submucosal lesions is showing encouraging results due to its sensitivity which ranges from 80 to 100% [14].
The histogenesis of HP tissue is controversial. Yamagiwa et al. [15] suggested that Heinrich type I HP of the stomach was caused by migration from fetal pancreas, while Heinrich type II and III heterotopic pancreas arises through erroneous differentiation of primitive gastric mucosal epithelium. The real incidence of HP into the stomach is uncertain; in a large series [15-16]. They examined the whole stomach by numerous sections in gastrectomies. They showed 107 cases of heterotopic pancreas out of 5,446 surgically resected stomachs; the incidence was 1.2%. Reported 12.7% incidence of cancer in their series of HP in the 1980 [17].
The review of the literature, showed 14 cases well documented of neoplasm arising from pancreatic ectopia in the stomach (Table 1). The site most involved is the antrum and generally the lesion was well confinated into in stomach wall. Surgery ranged from small resection to total gastrectomy. Overall survival was good. No case of diffuse cancer as our case has been described in the past. The majority of carcinomas arising with in HP are adenocarcinoma sorana plastic carcinomas. Review of the literature reveals adenocarcinomas arising within heterotopic pancreas to have a better prognosis than patients with adenocarcinoma of the pancreas.
In conclusion, based on the literature the findings of HP is not so uncommon. The gastric localization of HP is most common among the number of HP, but, based on literature’s data, more than ten cases developed cancer. The correct approach for diagnosis includes endoscopic ultrasound with several biopsies, fine needle aspiration and CT scan. A resection remains the gold standard if HP is suspected.


Table 1

Another alt text

Table 1
Showed 14 cases well documented of neoplasm arising from pancreatic ectopia in the stomach.

References

  1. Tanaka K, Tsunoda T, Eto T. Diagnosis and management of heterotopic pancreas. Int Surg. 1993; 78: 32-35.
  2. Lai EC, Tompskins RK. Heterotopic pancreas: review of a 26 year experience. Am J Surg. 1986; 151(6): 697-700.
  3. Hickman DM, Frey CF, Carson JW. Adenocarcinoma arising ingastric heterotopic pancreas. West J Med. 1981;135(1):57e62.
  4. Jeong HY, Yang HW, Seo SW. Adenocarcinoma Arising from an Ectopic Pancreas in the Stomach. Endoscopy. 2002; 34(4): 1014-1017.
  5. Guillou L, Nordback P, Gerber C. Ductal adenocarcinoma arising in a heterotopic pancreas situated in a hiatal hernia. Arch Pathol Lab Med. 1994; 118(5): 568.
  6. von Heinrich H. Ein Beitrag zur Histologie des sogen: Akzessorischen Pankreas. Virchows Arch A Pathol Anat Histopathol. 1909; 198: 392-401.
  7. Pang LC. Pancreatic heterotopia: a reappraisal and clinicopathologic analysis of 32 cases. South Med J. 1988; 81(10): 1264-1275.
  8. Cho JS, Shin KS, Kwon ST, Kim JW, Song CJ, Noh SM, et al. Heterotopic pancreas in the stomach: CT findings. Radiology. 2000; 217(7): 139-144.
  9. Kim JY, Lee JM, Kim KW, Park HS, Choi JY, Kim SH, et al. Ectopic pancreas: CT findings with emphasis on differentiation from small gastrointestinal stromal tumorand leiomyoma. Radiology. 2009; 252: 92-100.
  10. Shaib YH, Rabaa E, Feddersen RM, Jamal MM, Qaseem T. Gastricoutlet obstruction secondary to heterotopic pancreas in the antrum:case report and review. Gastrointest Endosc. 2001; 54(4): 527-530.
  11. Li-Xin Jiang, Jie Xu, Xue-Wen Wang. Gastric outlet obstruction caused by heterotopic pancreas:A case report and a quick review. World J Gastroenterol 2008; 14(43): 6757-6759.
  12. Rodriguez FJ, Abraham SC, Allen MS. Fine-needle aspiration cytology findings from a case of pancreatic heterotopia at the gastroesophageal junction. Diagn Cytopathol 2004; 31(3): 175-179.
  13. Gurocak B, Gokturk HS, Kayacetin S. A rare case of heterotopic pancreas in the stomach which caused closed perforation. Neth J Med. 2009; 67(7): 285-7.
  14. Christodoulidis G, Zacharoulis D, Barbanis S, Katsogridakis E, Hatzitheofilou K. Heterotopic pancreas in the stomach: A case report and literature review. World J Gastroenterol. 2007; 13(45): 6098-100.
  15. Yamagiwa H, Ishihara A, Sekoguchi T, Matsuzaki O. Heterotopic pancreas in surgically resected stomach. Gastroenterol Jpn. 1977; 12: 380-386.
  16. Yamagiwa H, Onishi N, Nishi M. Heterotopic pancreas of the stomach. Histogenesis and immunohisto chemistry. Acta Pathol Jpn. 1992; 42(4): 249-254.
  17. Nakaoa T, Yanoh K, Itoh A. Aberrant pancreas in Japan. In: Review of the literature and report of 12 surgical cases, 30. MedJ Osaka University; 1980. p. 57e63.